image
Ultragenyx Pharmaceutical Inc. RARE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 37.14
-0.562 %
$ 3.51 B
Market Cap
-6.37
P/E
Price Target Average
141.65%
Revenue Forecast Estimate
44.95%
EBIT Estimate
--42.44%
Net Income Estimate
33.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Ultragenyx Pharmaceutical Inc.
image
Wall Street analysts predict an average 1-year price target for RARE of $89.8 , with forecasts ranging from a low of $64 to a high of $115 .
RARE Lowest Price Target Wall Street Target
64 USD 72.32%
RARE Average Price Target Wall Street Target
89.8 USD 141.65%
RARE Highest Price Target Wall Street Target
115 USD 209.64%
Price
Max Price Target
Min Price Target
Average Price Target
1201201101101001009090808070706060505040403030May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Dec '24Dec '24Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Aug '25Aug '25Oct '25Oct '25Dec '25Dec '25Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart RARE

image
$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.02016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RARE

image
$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RARE

image
$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029